Patents by Inventor Yuki HANYA

Yuki HANYA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compound
    Patent number: 10202376
    Abstract: Provided is a compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and is useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, (excluding N-(4-bromo-3-(1H-1,2,4-triazol-5-yl)thiophen-2-yl)-2-(imidazo[1,2-a]pyridin-5-yl)acetamide) or a salt thereof.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: February 12, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Eiji Kimura, Yuhei Miyanohana, Masaki Ogino, Yuta Tanaka, Makoto Fushimi, Tomohiro Okawa, Yuki Hanya, Tatsuki Koike
  • HETEROCYCLIC COMPOUND
    Publication number: 20170362223
    Abstract: Provided is a compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and is useful as a prophylactic or therapeutic agent for major depression, bipolar disorder, migraine, pain, peripheral symptoms of dementia and the like. A compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, (excluding N-(4-bromo-3-(1H-1,2,4-triazol-5-yl)thiophen-2-yl)-2-(imidazo[1,2-a]pyridin-5-yl)acetamide) or a salt thereof.
    Type: Application
    Filed: December 21, 2015
    Publication date: December 21, 2017
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Eiji KIMURA, Yuhei MIYANOHANA, Masaki OGINO, Yuta TANAKA, Makoto FUSHIMI, Tomohiro OKAWA, Yuki HANYA, Tatsuki KOIKE